Literature DB >> 8432861

Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.

M C Cheung1, A J Mendez, A C Wolf, R H Knopp.   

Abstract

A 48-yr-old Caucasian female of central European origin (subject IM) with low plasma cholesterol and normal plasma triglyceride (TG) had extremely low apo A-I (6 mg/dl), A-II (5 mg/dl), and HDL cholesterol (2 mg/dl) levels. She had most of the clinical symptoms typically associated with Tangier disease, including early corneal opacities, yellow-streaked tonsils, hepatomegaly, and variable degrees of peripheral neuropathy, but had no splenomegaly. She had a myocardial infarction at age 46. Since HDL are postulated to be involved in the transport of excess cholesterol from peripheral tissues to the liver for degradation, and the ability of an HDL particle to promote cellular cholesterol efflux appears to be related to its density, size, and apo A-I and A-II contents, we isolated and characterized the HDL particles of this patient and all her first degree relatives (mother, a brother, and two children). The plasma A-I, A-II, and HDL cholesterol levels of all five relatives were either normal or high. Using anti-A-I and anti-A-II immunosorbents, we found three populations of particles in IM: one contained both apo A-I and A-II, Lp(AI w AII); one contained apo A-I but no A-II, Lp(AI w/o AII); and the third (an unusual one) contained apo A-II but no A-I, Lp(AII). Two-thirds of her plasma A-I and A-II existed in separate HDL particles, i.e., in Lp(AI w/o AII) and Lp(AII), respectively. Only Lp(AI w AII) and Lp(AI w/o AII) were present in the plasma of the relatives. All three populations of the patient's HDL particles had a normal core/surface lipid ratio, but the cores were enriched with TG. The apo A-I-containing particles, however, were considerably smaller and contained much less lipid than Lp(AII). Despite these unusual physicochemical characteristics, the apo A-I-containing particles and Lp(AII) were effective suppressors of intracellular cholesterol esterification in cholesterol-loaded human skin fibroblast. The patient's plasma apo D and lecithin cholesterol acyltransferase levels were reduced, with an increased proportion located in non-HDL plasma fractions. These findings are discussed in light of Tangier disease and other known HDL-deficiency cases, and the role of HDL in the maintenance of cell cholesterol homeostasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432861      PMCID: PMC287973          DOI: 10.1172/JCI116231

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cells by fractions of human high-density apolipoprotein.

Authors:  Y Stein; M C Glangeaud; M Fainaru; O Stein
Journal:  Biochim Biophys Acta       Date:  1975-01-24

2.  Isolation and characterization of an abnormal high density lipoprotein in Tangier Diesase.

Authors:  G Assmann; P N Herbert; D S Fredrickson; T Forte
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins.

Authors:  G Assmann; E Smootz; K Adler; A Capurso; K Oette
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

4.  Properties of the plasma very low and low density lipoproteins in Tangier disease.

Authors:  R J Heinen; P N Herbert; D S Fredrickson
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

6.  Quantitation of apolipoprotein A-I of human plasma high density lipoprotein.

Authors:  J J Albers; P W Wahl; V G Cabana; W R Hazzard; J J Hoover
Journal:  Metabolism       Date:  1976-06       Impact factor: 8.694

7.  Immunoassay of human plasma apolipoprotein B.

Authors:  J J Albers; V G Cabana; W R Hazzard
Journal:  Metabolism       Date:  1975-12       Impact factor: 8.694

Review 8.  The plasma lecithins:cholesterol acyltransferase reaction.

Authors:  J A Glomset
Journal:  J Lipid Res       Date:  1968-03       Impact factor: 5.922

9.  The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay.

Authors:  M C Cheung; J J Albers
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

10.  A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities.

Authors:  H Funke; A von Eckardstein; P H Pritchard; M Karas; J J Albers; G Assmann
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

View more
  7 in total

1.  Common variants near ABCA1 and in PMM2 are associated with primary open-angle glaucoma.

Authors:  Yuhong Chen; Ying Lin; Eranga N Vithana; Liyun Jia; Xianbo Zuo; Tien Yin Wong; Li Jia Chen; Xianjun Zhu; Pancy O S Tam; Bo Gong; Shaohong Qian; Zheng Li; Xiaoqi Liu; Baskaran Mani; Qian Luo; Celeste Guzman; Christopher K S Leung; Xiaobo Li; Wenjun Cao; Quanyao Yang; Clement C Y Tham; Yilian Cheng; Xuejun Zhang; Ningli Wang; Tin Aung; Chiea Chuen Khor; Chi Pui Pang; Xinghuai Sun; Zhenglin Yang
Journal:  Nat Genet       Date:  2014-08-31       Impact factor: 38.330

2.  Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.

Authors:  G A Francis; R H Knopp; J F Oram
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

3.  Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.

Authors:  D S Ng; L A Leiter; C Vezina; P W Connelly; R A Hegele
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

Review 4.  Thermosensory and mechanosensory perception in human genetic disease.

Authors:  Perciliz L Tan; Nicholas Katsanis
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

5.  Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans.

Authors:  C H Warden; A Daluiski; X Bu; D A Purcell-Huynh; C De Meester; B H Shieh; D L Puppione; R M Gray; G M Reaven; Y D Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

6.  Postprandial hypertriglyceridaemia in patients with Tangier disease.

Authors:  G Kolovou; D Daskalova; K Anagnostopoulou; I Hoursalas; V Voudris; D P Mikhailidis; D V Cokkinos
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

7.  Effect of two lipid-lowering strategies on high-density lipoprotein function and some HDL-related proteins: a randomized clinical trial.

Authors:  Chan Joo Lee; Seungbum Choi; Dong Huey Cheon; Kyeong Yeon Kim; Eun Jeong Cheon; Soo-Jin Ann; Hye-Min Noh; Sungha Park; Seok-Min Kang; Donghoon Choi; Ji Eun Lee; Sang-Hak Lee
Journal:  Lipids Health Dis       Date:  2017-02-28       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.